JCR Pharmaceuticals.
$3.73
4
+$0.13+3.61%Monday 15:57
Statistics
Day High
3.6
Day Low
3.6
52W High
4.75
52W Low
3.15
Volume
100
Avg. Volume
13
Mkt Cap
483.73M
P/E Ratio
-
Dividend Yield
3.41%
Dividend
0.13
Upcoming
Dividends
3.41%Dividend Yield
Jun 2026
$0.06
Dec 2025
$0.06
Jun 2025
$0.07
Dec 2024
$0.07
Jun 2024
$0.06
10Y Growth
9.65%
5Y Growth
2.62%
3Y Growth
-4.12%
1Y Growth
-7.1%
Earnings
Oct 29Expected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.36
-0.19
-0.03
0.14
Expected EPS
0.001069356019
Actual EPS
N/A
Financials
0.66%Profit Margin
Profitable575.72MRevenue
3.77MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow JCRRF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells, imports, and exports medical devices; and purchases and sells medical and research equipment. The company has a collaboration agreement with Angelini Pharma for the development of novel biologic therapies; and a. joint research agreement with Modalis Therapeutics Corporation to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was founded in 1975 and is based in Ashiya, Japan.
Show More
CEO
Toru Ashida
Employees
985
Country
Japan
ISIN
JP3701000006
WKN
000889627
Listings
0 Comments
Share your thoughts
FAQs
What is JCR Pharmaceuticals. stock price today?▼
The current price of JCRRF is $3.73 USD — it has increased by +3.61% in the past 24 hours. Watch JCR Pharmaceuticals. stock price performance more closely on the chart.
What is JCR Pharmaceuticals. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange JCR Pharmaceuticals. stocks are traded under the ticker JCRRF.
What is JCR Pharmaceuticals. market cap?▼
Today JCR Pharmaceuticals. has the market capitalization of 483.73M
When is the next JCR Pharmaceuticals. earnings date?▼
JCR Pharmaceuticals. is going to release the next earnings report on October 29, 2026.
What were JCR Pharmaceuticals. earnings last quarter?▼
JCRRF earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.07 USD resulting in a -38.78% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is JCR Pharmaceuticals. revenue for the last year?▼
JCR Pharmaceuticals. revenue for the last year amounts to 575.72M USD.
What is JCR Pharmaceuticals. net income for the last year?▼
JCRRF net income for the last year is 3.77M USD.
Does JCR Pharmaceuticals. pay dividends?▼
Yes, JCRRF dividends are paid semi-annual. The last dividend per share was 0.06 . As of today, Dividend Yield (FWD)% is 3.41%.
How many employees does JCR Pharmaceuticals. have?▼
As of October 9, 2026, the company has 985 employees.
In which sector is JCR Pharmaceuticals. located?▼
JCR Pharmaceuticals. operates in the Health & Wellness sector.
When did JCR Pharmaceuticals. complete a stock split?▼
The last stock split for JCR Pharmaceuticals. was on September 29, 2020 with a ratio of 4:1.
Where is JCR Pharmaceuticals. headquartered?▼
JCR Pharmaceuticals. is headquartered in Ashiya, Japan.